These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15157250)

  • 1. Persistence of cefotetan on red blood cells.
    Davenport RD; Judd WJ; Dake LR
    Transfusion; 2004 Jun; 44(6):849-52. PubMed ID: 15157250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and laboratory study of an episode of cefotetan-induced severe hemolytic anemia.
    Franchini M; Piccoli PL; Gandini G; Giuffrida A; Bressan F; De Gironcoli M; Aprili G
    Hematology; 2004 Feb; 9(1):65-9. PubMed ID: 14965871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reactivity of cefotetan and ceftriaxone antibodies, associated with hemolytic anemia, with other: cephalosporins and penicillin.
    Arndt PA; Garratty G
    Am J Clin Pathol; 2002 Aug; 118(2):256-62. PubMed ID: 12162687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests.
    Arndt PA; Leger RM; Garratty G
    Transfusion; 1999; 39(11-12):1239-46. PubMed ID: 10604252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal immune hemolytic anemia due to cefotetan.
    Garratty G; Nance S; Lloyd M; Domen R
    Transfusion; 1992; 32(3):269-71. PubMed ID: 1557811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The first case of drug-induced immune hemolytic anemia due to hydrocortisone.
    Martinengo M; Ardenghi DF; Tripodi G; Reali G
    Transfusion; 2008 Sep; 48(9):1925-9. PubMed ID: 18565121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefotetan-induced immune hemolytic anemia following prophylaxis for cesarean delivery.
    Shariatmadar S; Storry JR; Sausais L; Reid ME
    Immunohematology; 2004; 20(1):63-6. PubMed ID: 15373671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorption.
    Arndt P; Garratty G; Isaak E; Bolger M; Lu Q
    Transfusion; 2009 Apr; 49(4):711-8. PubMed ID: 19192254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced hemolysis: cefotetan-dependent hemolytic anemia mimicking an acute intravascular immune transfusion reaction.
    Stroncek D; Procter JL; Johnson J
    Am J Hematol; 2000 May; 64(1):67-70. PubMed ID: 10815791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefotetan-induced hemolytic anemia after perioperative prophylaxis.
    Martin ME; Laber DA
    Am J Hematol; 2006 Mar; 81(3):186-8. PubMed ID: 16493619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One center's experience: the serology and drugs associated with drug-induced immune hemolytic anemia--a new paradigm.
    Johnson ST; Fueger JT; Gottschall JL
    Transfusion; 2007 Apr; 47(4):697-702. PubMed ID: 17381629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune hemolytic anemia caused by drugs.
    Garratty G
    Expert Opin Drug Saf; 2012 Jul; 11(4):635-42. PubMed ID: 22502777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia.
    Arndt PA; Leger RM; Garratty G
    Transfusion; 2012 Mar; 52(3):602-12. PubMed ID: 21880048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe immune-mediated hemolytic anemia secondary to treatment with cefotetan.
    Gallagher NI; Schergen AK; Sokol-Anderson ML; Sheahan EJ; Chaplin H
    Transfusion; 1992; 32(3):266-8. PubMed ID: 1557810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced immune hemolytic anemia.
    Garratty G
    Hematology Am Soc Hematol Educ Program; 2009; ():73-9. PubMed ID: 20008184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefotetan-induced immune hemolytic anemia.
    Chenoweth CE; Judd WJ; Steiner EA; Kauffman CA
    Clin Infect Dis; 1992 Nov; 15(5):863-5. PubMed ID: 1445986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death.
    Chadebech P; Habibi A; Nzouakou R; Bachir D; Meunier-Costes N; Bonin P; Rodet M; Chami B; Galacteros F; Bierling P; Noizat-Pirenne F
    Transfusion; 2009 Sep; 49(9):1785-92. PubMed ID: 19413729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of potential immune response and in vivo survival of riboflavin-ultraviolet light-treated red blood cells in baboons.
    Goodrich RP; Murthy KK; Doane SK; Fitzpatrick CN; Morrow LS; Arndt PA; Reddy HL; Buytaert-Hoefen KA; Garratty G
    Transfusion; 2009 Jan; 49(1):64-74. PubMed ID: 18954398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The production of red blood cell alloantibodies in mice transfused with blood from transgenic Fyb-expressing mice.
    Campbell-Lee SA; Liu J; Velliquette RW; Halverson GR; Shirey RS; Chaudhuri A; Reid ME; Ness PM; Baldwin WM
    Transfusion; 2006 Oct; 46(10):1682-8. PubMed ID: 17002623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passenger lymphocyte syndrome with or without immune hemolytic anemia in all Rh-positive recipients of lungs from rhesus alloimmunized donors: three new cases and a review of the literature.
    Cserti-Gazdewich CM; Waddell TK; Singer LG; Chaparro C; Pendergrast JM; Hawes J; denHollander N; Tinckam K; Keshavjee S
    Transfus Med Rev; 2009 Apr; 23(2):134-45. PubMed ID: 19304114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.